×
QQQ   299.33 (+2.77%)
AAPL   143.78 (+2.32%)
MSFT   265.90 (+1.29%)
FB   191.63 (+4.24%)
GOOGL   2,155.85 (+1.88%)
AMZN   2,221.55 (+4.03%)
TSLA   707.73 (+7.43%)
NVDA   178.51 (+5.16%)
BABA   94.48 (+14.79%)
NIO   16.03 (+9.49%)
AMD   98.75 (+6.58%)
CGC   5.55 (+10.34%)
MU   70.60 (+4.02%)
T   21.32 (+0.09%)
GE   77.01 (+3.33%)
F   13.12 (+3.23%)
DIS   105.61 (+2.28%)
AMC   12.23 (+2.95%)
PFE   53.99 (+0.52%)
PYPL   80.42 (+0.37%)
NFLX   191.40 (+1.90%)
QQQ   299.33 (+2.77%)
AAPL   143.78 (+2.32%)
MSFT   265.90 (+1.29%)
FB   191.63 (+4.24%)
GOOGL   2,155.85 (+1.88%)
AMZN   2,221.55 (+4.03%)
TSLA   707.73 (+7.43%)
NVDA   178.51 (+5.16%)
BABA   94.48 (+14.79%)
NIO   16.03 (+9.49%)
AMD   98.75 (+6.58%)
CGC   5.55 (+10.34%)
MU   70.60 (+4.02%)
T   21.32 (+0.09%)
GE   77.01 (+3.33%)
F   13.12 (+3.23%)
DIS   105.61 (+2.28%)
AMC   12.23 (+2.95%)
PFE   53.99 (+0.52%)
PYPL   80.42 (+0.37%)
NFLX   191.40 (+1.90%)
QQQ   299.33 (+2.77%)
AAPL   143.78 (+2.32%)
MSFT   265.90 (+1.29%)
FB   191.63 (+4.24%)
GOOGL   2,155.85 (+1.88%)
AMZN   2,221.55 (+4.03%)
TSLA   707.73 (+7.43%)
NVDA   178.51 (+5.16%)
BABA   94.48 (+14.79%)
NIO   16.03 (+9.49%)
AMD   98.75 (+6.58%)
CGC   5.55 (+10.34%)
MU   70.60 (+4.02%)
T   21.32 (+0.09%)
GE   77.01 (+3.33%)
F   13.12 (+3.23%)
DIS   105.61 (+2.28%)
AMC   12.23 (+2.95%)
PFE   53.99 (+0.52%)
PYPL   80.42 (+0.37%)
NFLX   191.40 (+1.90%)
QQQ   299.33 (+2.77%)
AAPL   143.78 (+2.32%)
MSFT   265.90 (+1.29%)
FB   191.63 (+4.24%)
GOOGL   2,155.85 (+1.88%)
AMZN   2,221.55 (+4.03%)
TSLA   707.73 (+7.43%)
NVDA   178.51 (+5.16%)
BABA   94.48 (+14.79%)
NIO   16.03 (+9.49%)
AMD   98.75 (+6.58%)
CGC   5.55 (+10.34%)
MU   70.60 (+4.02%)
T   21.32 (+0.09%)
GE   77.01 (+3.33%)
F   13.12 (+3.23%)
DIS   105.61 (+2.28%)
AMC   12.23 (+2.95%)
PFE   53.99 (+0.52%)
PYPL   80.42 (+0.37%)
NFLX   191.40 (+1.90%)
NASDAQ:AIMT

Aimmune Therapeutics Earnings Date, Estimates, & History

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
$34.49
$34.49
50-Day Range
$34.30
$34.59
52-Week Range
$10.09
$37.00
Volume
N/A
Average Volume
1.71 million shs
Market Capitalization
$2.26 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.76
Skip Charts & View Estimated and Actual Earnings Data

Aimmune Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Aimmune Therapeutics Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Aimmune Therapeutics (NASDAQ:AIMT) Earnings Estimates

Current Year EPS Consensus Estimate: $-4.35 EPS
Next Year EPS Consensus Estimate: $-2.93 EPS

Aimmune Therapeutics (NASDAQ:AIMT) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
7/30/20206/30/2020($1.06)($1.06)($1.06)$1.20 million  
5/11/20203/31/2020($1.18)($1.34)($0.16)($1.02)$1.34 million$0.58 million  
2/27/2020Q4($1.06)($1.06)($1.06)  
11/6/2019Q3($1.03)($1.03)($1.03)  
8/8/2019Q2 2019($0.93)($1.008760)($0.078760)($1.01)  
5/8/20193/31/2019($0.94)($0.87)+$0.07($0.87)  
2/28/2019Q4 2018($0.84)($0.95)($0.11)($0.95)
11/8/2018Q3($0.92)($0.89)+$0.03($0.89)
8/8/2018Q2 2018($0.86)($0.91)($0.05)($0.91)
5/8/2018Q1 2018($0.7110)($0.9240)($0.2130)($0.92)
3/12/2018Q4 2017($0.72)($0.81)($0.09)($0.81)
11/6/2017Q3 2017($0.72)($0.63)+$0.09($0.63)
8/8/2017Q2($0.64)($0.65)($0.01)($0.65)
5/8/2017Q1 2017($0.57)($0.52)+$0.05($0.52)
3/15/2017Q4 2016($0.47)($0.55)($0.08)($0.55)
11/14/2016Q3 2016($0.4460)($0.53)($0.0840)($0.53)
8/10/2016Q216($0.42)($0.43)($0.01)($0.43)
5/16/2016Q116($0.40)($0.37)+$0.03($0.37)
3/3/2016Q415($0.35)($0.39)($0.04)($0.39)  
11/4/2015Q3 2015($0.24)($0.36)($0.12)($0.36)
8/31/2015Q2 2015($1.60)($1.60)($1.60)
(Earnings results data provided by Zacks Investment Research)












Aimmune Therapeutics (NASDAQ:AIMT) Earnings Frequently Asked Questions

How much profit does Aimmune Therapeutics generate each year?

Aimmune Therapeutics (NASDAQ:AIMT) has a recorded net income of -$248.50 million. AIMT has generated -$3.97 earnings per share over the last four quarters.

What is Aimmune Therapeutics's EPS forecast for next year?

Aimmune Therapeutics's earnings are expected to grow from ($4.35) per share to ($2.93) per share in the next year.

This page was last updated on 5/26/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.